Research ArticleRadionuclide Therapy
Dose-Dependent Growth Delay of Breast Cancer Xenografts in the Bone Marrow of Mice Treated with 223Ra: The Role of Bystander Effects and Their Potential for Therapy
Calvin N. Leung, Brian S. Canter, Didier Rajon, Tom A. Bäck, J. Christopher Fritton, Edouard I. Azzam and Roger W. Howell
Journal of Nuclear Medicine January 2020, 61 (1) 89-95; DOI: https://doi.org/10.2967/jnumed.119.227835
Calvin N. Leung
1Department of Radiology, New Jersey Medical School, Rutgers University, Newark, New Jersey
Brian S. Canter
1Department of Radiology, New Jersey Medical School, Rutgers University, Newark, New Jersey
2Department of Orthopedics, New Jersey Medical School, Rutgers University, Newark, New Jersey
Didier Rajon
3Department of Neurosurgery, University of Florida, Gainesville, Florida; and
Tom A. Bäck
4Department of Radiation Physics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
J. Christopher Fritton
2Department of Orthopedics, New Jersey Medical School, Rutgers University, Newark, New Jersey
Edouard I. Azzam
1Department of Radiology, New Jersey Medical School, Rutgers University, Newark, New Jersey
Roger W. Howell
1Department of Radiology, New Jersey Medical School, Rutgers University, Newark, New Jersey

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 1
January 1, 2020
Dose-Dependent Growth Delay of Breast Cancer Xenografts in the Bone Marrow of Mice Treated with 223Ra: The Role of Bystander Effects and Their Potential for Therapy
Calvin N. Leung, Brian S. Canter, Didier Rajon, Tom A. Bäck, J. Christopher Fritton, Edouard I. Azzam, Roger W. Howell
Journal of Nuclear Medicine Jan 2020, 61 (1) 89-95; DOI: 10.2967/jnumed.119.227835
Dose-Dependent Growth Delay of Breast Cancer Xenografts in the Bone Marrow of Mice Treated with 223Ra: The Role of Bystander Effects and Their Potential for Therapy
Calvin N. Leung, Brian S. Canter, Didier Rajon, Tom A. Bäck, J. Christopher Fritton, Edouard I. Azzam, Roger W. Howell
Journal of Nuclear Medicine Jan 2020, 61 (1) 89-95; DOI: 10.2967/jnumed.119.227835
Jump to section
Related Articles
Cited By...
- MIRD Pamphlet No. 31: MIRDcell V4--Artificial Intelligence Tools to Formulate Optimized Radiopharmaceutical Cocktails for Therapy
- MIRD Pamphlet No. 27: MIRDcell V3, a Revised Software Tool for Multicellular Dosimetry and Bioeffect Modeling
- Enhancing 223Ra Treatment Efficacy by Anti-{beta}1 Integrin Targeting
- Radium-223-Induced Bystander Effects Cause DNA Damage and Apoptosis in Disseminated Tumor Cells in Bone Marrow